Glipizide
Product Images NDC 61145-202

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 61145-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Repharm Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glipizide Tablets 10 mg Bottle Label (500ct. 10 mg Glipizide Tablets Usp (repharm))

Each tablet contains 10mg of Glipizide, USP. This medication is available as tablets, USP. It is important to store this and all medications out of the reach of children, in a tight, light-resistant container with a child-resistant closure. The container should be lightly closed and stored at a temperature between 20° to 25°C (63° to 77°F), as defined in the USP Controlled Room Temperature. The usual dosage is available in the accompanying prescribing information. This container is not intended for household use. This medication is produced by Repharm Pharmaceuticals Inc., located in Riverside, MO 64150 USA.*

FDA Label Image

Glipizide Tablets 5 mg Bottle Label (500ct. 5 mg Glipizide Tablets Usp (repharm))

This is a medication container that contains Glipizids tablets. It is recommended to keep the container tightly closed and out of reach of children in a child-resistant closure. The usual dosage should be followed as prescribed by the doctor. The container is not intended for dispensing or household use. The tablet should be stored at 20° to 25°C. The package contains 500 tablets.*

FDA Label Image

Glipizide Structural Formula (Glipizide Structural Formula)

FDA Label Image

Image Description (Repharm Logo)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.